Disclosures for "Reversal of Vision Metamorphopsia and Hallucinations in a Cerebellar Peduncle Stroke: A Case Report"
-
Dr. Sadeghifar has nothing to disclose.
-
Dr. Mulo has nothing to disclose.
-
Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext.
-
Dr. Wang has nothing to disclose.